BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7145597)

  • 1. Plasma progesterone levels after using high dose suppositories. A preliminary report.
    van der Meer YG; van Loenen AC; Loendersloot EW; Jaszmann LJ
    Pharm Weekbl Sci; 1982 Oct; 4(5):135-6. PubMed ID: 7145597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone.
    Nillius SJ; Johansson ED
    Am J Obstet Gynecol; 1971 Jun; 110(4):470-7. PubMed ID: 5582003
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration.
    Mircioiu C; Perju A; Neagu A; Griu E; Calin G; Miron DS
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):391-6. PubMed ID: 9842982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma progesterone levels after intramuscular or rectal administration of progesterone.
    Nillius SJ; Johansson ED
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:46. PubMed ID: 5287114
    [No Abstract]   [Full Text] [Related]  

  • 6. Artificially induced menstrual cycle with natural estradiol and progesterone.
    Hung TT; Ribas D; Tsuiki A; Preyer J; Slackman R; Davidson OW
    Fertil Steril; 1989 Jun; 51(6):968-71. PubMed ID: 2498134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sustained-release progesterone vaginal suppositories 3-development and clinical feasibility testing].
    Nakayama A; Yamaguchi N; Ohno Y; Miyata C; Kondo H; Sunada H; Okamoto H
    Yakugaku Zasshi; 2013; 133(6):727-36. PubMed ID: 23728096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of natural progesterone vaginal suppository.
    von Eye Corleta H; Capp E; Ferreira MB
    Gynecol Obstet Invest; 2004; 58(2):105-8. PubMed ID: 15192285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of nasally administered progesterone.
    Steege JF; Rupp SL; Stout AL; Bernhisel M
    Fertil Steril; 1986 Oct; 46(4):727-9. PubMed ID: 3758397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma progesterone concentrations after administration via intravaginal rings.
    Bäckström T; von Schoultz B; Toivonen J
    Acta Obstet Gynecol Scand; 1979; 58(2):211-2. PubMed ID: 452876
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositories.
    Fulper LD; Cleary RW; Harland EC; Hikal AH; Jones AB
    Am J Obstet Gynecol; 1987 Jan; 156(1):253-6. PubMed ID: 3799758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences in the treatment of prostatic hypertrophy with high doses of progesterone administered rectally].
    Marini A; Cavalca GG
    Minerva Urol; 1974; 26(3):140-5. PubMed ID: 4138638
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative bioavailability of orally and vaginally administered progesterone.
    Norman TR; Morse CA; Dennerstein L
    Fertil Steril; 1991 Dec; 56(6):1034-9. PubMed ID: 1743318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs].
    Tan T; Kitamura K; Yamanaka M; Kojima K; Nakanishi Y; Arakawa S
    Yakugaku Zasshi; 1990 Jun; 110(6):434-41. PubMed ID: 2213530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration.
    Ottoson UB; Carlstrom K; Damber JE; von Schoultz B
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1111-9. PubMed ID: 6498126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of progesterone achieved by different routes of administration.
    Johansson ED
    Acta Obstet Gynecol Scand Suppl; 1972; 19():17-20. PubMed ID: 4508283
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum progesterone levels following vaginal administration of progesterone during the luteal phase.
    Myers ER; Sondheimer SJ; Freeman EW; Strauss JF; Rickels K
    Fertil Steril; 1987 Jan; 47(1):71-5. PubMed ID: 3792576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of phenytoin from rectal suppositories formulated with a polyethylene glycol base.
    Burstein AH; Fisher KM; McPherson ML; Roby CA
    Pharmacotherapy; 2000 May; 20(5):562-7. PubMed ID: 10809343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of diazepam and its metabolites after peroral, intramuscular, and rectal administration. Correlation between plasma concentration and sedatory effect of diazepam.
    Kanto J
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):427-32. PubMed ID: 1205656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.